Replies to post #66 on RetinalGeniX Technologies Inc (RTGN)

[~S.B.A.~]

"initiate patient enrollment for its combined Phase 1/2 clinical trial in the prevention of infection post abdominal surgery for RUT58-60 in July 2014"

Would make sense for an IR/PR campaign to start in that timeframe